Following a transurethral resection (TUR) prostatectomy for a benign enlargement, the patient complains of the lack of ejaculation and little emission, although he has a good erection. He does not ...
TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results